Halozyme Reports Significant Recent Achievements And Second Quarter 2020 Results

Go back to Halozyme Reports Significant Recent Achievements And Second Quarter 2020 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.00 --0 (-0%)
Previous Close $107.00    52 Week High $18.39 
Open $107.00    52 Week Low $6.96 
Day High $107.00    P/E N/A 
Day Low $107.00    EPS $-0.58 
Volume 10,865